Nautilus Biotechnology, Inc. Common Stock Shares Outstanding

• Nautilus Biotechnology, Inc. showed an increase of +0.3% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Nautilus Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2020 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2020 to 2025), Nautilus Biotechnology, Inc.'s Common Stock Shares Outstanding has grown by 282.4%.
• Historical annual values: Fiscal year 2025: 126.47 million shares | Fiscal year 2024: 126.11 million shares | Fiscal year 2023: 125.07 million shares | Fiscal year 2022: 124.87 million shares | Fiscal year 2021: 124.30 million shares | Fiscal year 2021: 124.05 million shares | Fiscal year 2020: 33.07 million shares.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026